Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2w ago Cannabis greenmarketreport Views: 102

-

Recreational cannabis sales will kick off next month in Rhode Island for at least five existing medical dispensaries, Gov. Dan McKee announced today.

In a press release, McKee said he and the state Department of Business Regulation have granted “hybrid retail licenses” to the following five dispensaries:

  • Aura of Rhode Island (Central Falls)
  • Thomas C. Slater Center (Providence)
  • Mother Earth Wellness (Pawtucket)
  • Greenleaf Compassionate Care Center (Portsmouth)
  • RISE Warwick (Warwick)

Those shops will be allowed to commence adult-use cannabis sales on Dec. 1, McKee said.

“This milestone is the result of a carefully executed process to ensure that our state’s entry into this emerging market was done in a safe, controlled, and equitable manner,” McKee said. “It is also a win for our statewide economy and our strong, locally based cannabis supply chain, which consists of nearly 70 licensed cultivators, processors, and manufacturers in addition to our licensed compassion centers.”

The medical marijuana sector in Rhode Island, meanwhile, has been adjusting to new testing standards that were adopted this year, which prohibit certain pesticides and other contaminants, such as heavy metals and mold.

According to WPRI, nine companies thus far have had to destroy or quarantine batches of cannabis products due to failed test results for pesticide contamination, though none of the product in question was ever sold to patients.

Pesticide testing only began in June, which has led some cannabis executives to request that authorities revisit testing thresholds. Some argue that the bar for failure is set too low to be reasonable.

The same testing standards will also apply to recreational marijuana, and the same medical cannabis supply chain will be stocking the adult use market.

Rhode Island Green Lights Recreational Sales for Five Dispensaries on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.